A. A. Roger Thompson
A. A. Roger Thompson
Verified email at sheffield.ac.uk
TitleCited byYear
The 2018 Lake Louise Acute Mountain Sickness Score
RC Roach, PH Hackett, O Oelz, P Bärtsch, AM Luks, MJ MacInnis, ...
High altitude medicine & biology 19 (1), 4-6, 2018
8882018
MET is required for the recruitment of anti-tumoural neutrophils
V Finisguerra, G Di Conza, M Di Matteo, J Serneels, S Costa, ...
Nature 522 (7556), 349-353, 2015
1522015
Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice
SR Walmsley, ER Chilvers, AA Thompson, K Vaughan, HM Marriott, ...
The Journal of clinical investigation 121 (3), 1053-1063, 2011
1272011
Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial
JK Baillie, AAR Thompson, JB Irving, MGD Bates, AI Sutherland, ...
QJM 102 (5), 341-348, 2009
1202009
Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils
NN McGovern, AS Cowburn, L Porter, SR Walmsley, C Summers, ...
The Journal of Immunology 186 (1), 453-463, 2011
1062011
Endogenous urate production augments plasma antioxidant capacity in healthy lowland subjects exposed to high altitude
JK Baillie, MGD Bates, AAR Thompson, WS Waring, RW Partridge, ...
Chest 131 (5), 1473-1478, 2007
792007
Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish
AAR Thompson, PM Elks, HM Marriott, S Eamsamarng, KR Higgins, ...
Blood 123 (3), 366-376, 2014
762014
Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro
SJ Jackson, J Varley, C Sellers, K Josephs, L Codrington, G Duke, ...
High Altitude Medicine & Biology 11 (3), 217-222, 2010
552010
Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness
DA Dorward, AA Roger Thompson, J Kenneth Baillie, M MacDougall, ...
Respiratory medicine 101 (3), 587-594, 2007
452007
Mechanical activation of hypoxia-inducible factor 1α drives endothelial dysfunction at atheroprone sites
S Feng, N Bowden, M Fragiadaki, C Souilhol, S Hsiao, M Mahmoud, ...
Arteriosclerosis, thrombosis, and vascular biology 37 (11), 2087-2101, 2017
412017
Sildenafil Citrate for the Prevention of High Altitude Hypoxic Pulmonary Hypertension: Double Blind, Randomized, Placebo-Controlled Trial
MGD Bates, AAR Thompson, JK Baillie, AI Sutherland, JB Irving, N Hirani, ...
High Altitude Medicine & Biology 12 (3), 207-214, 2011
412011
Targeting vascular remodeling to treat pulmonary arterial hypertension
AAR Thompson, A Lawrie
Trends in molecular medicine 23 (1), 31-45, 2017
372017
Network analysis reveals distinct clinical syndromes underlying acute mountain sickness
DP Hall, IJC MacCormick, AT Phythian-Adams, NM Rzechorzek, ...
PloS one 9 (1), e81229, 2014
282014
Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses
P Sadiku, JA Willson, RS Dickinson, F Murphy, AJ Harris, A Lewis, ...
The Journal of Clinical Investigation 127 (9), 3407-3420, 2017
272017
Hypoxia, the HIF pathway and neutrophilic inflammatory responses
AA Thompson, J Binham, T Plant, MKB Whyte, SR Walmsley
Biological chemistry 394 (4), 471-477, 2013
262013
HIF-mediated innate immune responses: cell signaling and therapeutic implications
AJ Harris, AAR Thompson, MKB Whyte, SR Walmsley
252014
Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis
EE McGrath, A Lawrie, HM Marriott, P Mercer, SS Cross, N Arnold, ...
Thorax 67 (9), 796-803, 2012
252012
Hypoxia determines survival outcomes of bacterial infection through HIF-1α–dependent reprogramming of leukocyte metabolism
AAR Thompson, RS Dickinson, F Murphy, JP Thomson, HM Marriott, ...
Science Immunology 2 (8), eaal2861, 2017
242017
Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitude
EMD Smith, JK Baillie, AAR Thompson, JB Irving, D Porteous, DJ Webb
High altitude medicine & biology 7 (3), 221-227, 2006
222006
Phosphodiesterase type 5 inhibitors in the treatment and prevention of high altitude pulmonary edema.
MG Bates, AA Thompson, JK Baillie
Current opinion in investigational drugs (London, England: 2000) 8 (3), 226-231, 2007
212007
The system can't perform the operation now. Try again later.
Articles 1–20